Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Cyclosporine Versus Methotrexate in the Treatment of Pediatric Alopecia Areata in Routine Clinical Care: a Patient Preference Trial

NCT07381556 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT07381556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07381556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Cyclosporine Versus Methotrexate in the Treatment of Pediatric Alopecia Areata in Routine Clinical Care: a Patient Preference Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
November 1, 2025
Completion date
November 1, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata (& ophiasis), alopecia areata (aa), alopecia areata(aa), alopecia totalis (at), alopecia totalis/universalis, alopecia universalis (au)